% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Reuss:212546,
      author       = {D. E. Reuss$^*$},
      title        = {{U}pdates on the {WHO} diagnosis of {IDH}-mutant glioma.},
      journal      = {Journal of neuro-oncology},
      volume       = {162},
      number       = {3},
      issn         = {0167-594x},
      address      = {Dordrecht [u.a.]},
      publisher    = {Springer Science + Business Media B.V},
      reportid     = {DKFZ-2023-00231},
      pages        = {461-469},
      year         = {2023},
      note         = {#LA:B300# / 2023 May;162(3):461-469},
      abstract     = {The WHO classification of Tumors of the Central Nervous
                      System represents the international standard classification
                      for brain tumors. In 2021 the 5th edition (WHO CNS5) was
                      published, and this review summarizes the changes regarding
                      IDH-mutant gliomas and discusses unsolved issues and future
                      perspectives.This review is based on the 5th edition of the
                      WHO Blue Book of CNS tumors (WHO CNS5) and relevant related
                      papers.Major changes include taxonomy and nomenclature of
                      IDH-mutant gliomas. Essential and desirable criteria for
                      classification were established considering technical
                      developments. For the first time molecular features are not
                      only relevant for the classification of IDH-mutant gliomas
                      but may impact grading as well.WHO CNS5 classification moves
                      forward towards a classification which is founded on tumor
                      biology and serves clinical needs. The rapidly increasing
                      knowledge on the molecular landscape of IDH-mutant gliomas
                      is expected to further refine classification and grading in
                      the future.},
      subtyp        = {Review Article},
      keywords     = {CNS5 (Other) / Classification (Other) / Glioma (Other) /
                      IDH-mutant (Other) / Molecular pathology (Other) /
                      Neuropathology (Other) / WHO (Other)},
      cin          = {B300 / HD01},
      ddc          = {610},
      cid          = {I:(DE-He78)B300-20160331 / I:(DE-He78)HD01-20160331},
      pnm          = {312 - Funktionelle und strukturelle Genomforschung
                      (POF4-312)},
      pid          = {G:(DE-HGF)POF4-312},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:36717507},
      doi          = {10.1007/s11060-023-04250-5},
      url          = {https://inrepo02.dkfz.de/record/212546},
}